New York, NY -- (SBWIRE) -- 01/03/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Penn Virginia Corporation (NYSE:PVA), Thompson Creek Metals Company Inc (USA) (NYSE:TC), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Pengrowth Energy Corp (USA) (NYSE:PGH)
Penn Virginia Corporation (NYSE:PVA) showed a volume of 2.45 million shares by the end of last trade whereas the average volume of the stock remained 2.57 million shares. The stock opened the session at $9.40 but then moved to $9.21. At that price, the stock showed a negative performance of -2.33%. Penn Virginia Corporation (Penn Virginia) is an independent oil and gas company engaged primarily in the exploration, development and production of oil, natural gas liquids (NGL) and natural gas in various domestic onshore regions of the United States, including Texas, the Mid-Continent and Mississippi. As of December 31, 2012, the Company's proved reserves were approximately 113 million barrels of oil per day , of which 41% were proved developed reserves and 40% were oil and NGLs.
Will PVA Get Buyers Even After The Recent Rally? Find Out Here
Thompson Creek Metals Company Inc (USA) (NYSE:TC) opened the session at $2.20 and closed the session at $2.38. The stock showed a positive performance of 9.17% in previous trading session. Thompson Creek Metals Company Inc. is a diversified mining company. It is a producer of molybdenum and has copper and gold reserves. It operates in three segments: US Operations Molybdenum, Canadian Operations Molybdenum, and Copper-Gold (Development). The US Operations Molybdenum segment includes all mining, milling, mine site administration,
For How Long TC will fight for Profitability? Read This Trend Analysis report
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) opened the session at $0.93 and closed the session at $0.980. The stock showed a positive performance of 5.94% in previous trading session. Traded with volume of 2.42 million shares in the prior session and the average volume of the stock remained 4.12 million shares. The beta of the stock remained 2.71. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company’s products include ICT-107, ICT-140, ICT-121, ICT-109 and DIAAD. ICT-107, the pipeline product,
Why Should Investors Buy IMUC After The Recent Gain? Just Go Here and Find Out
Pengrowth Energy Corp (USA) (NYSE:PGH) the stock decreased -1.94% and finished the session at $6.08. Traded with volume of 2.34 million shares in the prior session and the average volume of the stock remained 1.31 million shares. The beta of the stock remained 1.52. Pengrowth Energy Corporation (Pengrowth) is engaged in the development, production and acquisition of, and the exploration for, oil and natural gas reserves in the provinces of Alberta, British Columbia, Saskatchewan, Ontario and Nova Scotia. The Company’s producing properties include Lindbergh, Swan Hills Area, Greater Olds/Garrington Area and Southeast Saskatchewan. In February 2012, the Company commenced the injection of steam at its Lindbergh pilot project. On May 31, 2012, the Company acquired NAL Energy Corporation.
Will PGH Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)